1
|
Liao R, Wood TR, Nance E. Nanotherapeutic modulation of excitotoxicity and oxidative stress in acute brain injury. Nanobiomedicine (Rij) 2020; 7:1849543520970819. [PMID: 35186151 PMCID: PMC8855450 DOI: 10.1177/1849543520970819] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Accepted: 10/13/2020] [Indexed: 12/20/2022] Open
Abstract
Excitotoxicity is a primary pathological process that occurs during stroke, traumatic brain injury (TBI), and global brain ischemia such as perinatal asphyxia. Excitotoxicity is triggered by an overabundance of excitatory neurotransmitters within the synapse, causing a detrimental cascade of excessive sodium and calcium influx, generation of reactive oxygen species, mitochondrial damage, and ultimately cell death. There are multiple potential points of intervention to combat excitotoxicity and downstream oxidative stress, yet there are currently no therapeutics clinically approved for this specific purpose. For a therapeutic to be effective against excitotoxicity, the therapeutic must accumulate at the disease site at the appropriate concentration at the right time. Nanotechnology can provide benefits for therapeutic delivery, including overcoming physiological obstacles such as the blood–brain barrier, protect cargo from degradation, and provide controlled release of a drug. This review evaluates the use of nano-based therapeutics to combat excitotoxicity in stroke, TBI, and hypoxia–ischemia with an emphasis on mitigating oxidative stress, and consideration of the path forward toward clinical translation.
Collapse
Affiliation(s)
- Rick Liao
- Department of Chemical Engineering, University of Washington, Seattle, WA, USA
| | - Thomas R Wood
- Department of Pediatrics, Division of Neonatology, University of Washington, Seattle, WA, USA
| | - Elizabeth Nance
- Department of Chemical Engineering, University of Washington, Seattle, WA, USA.,Department of Radiology, University of Washington, Seattle, WA, USA.,Center on Human Development and Disability, University of Washington, Seattle, WA, USA
| |
Collapse
|
2
|
Bolshakova O, Borisenkova A, Suyasova M, Sedov V, Slobodina A, Timoshenko S, Varfolomeeva E, Golomidov I, Lebedev V, Aksenov V, Sarantseva S. In vitro and in vivo study of the toxicity of fullerenols С 60, С 70 and С 120О obtained by an original two step method. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2019; 104:109945. [PMID: 31499967 DOI: 10.1016/j.msec.2019.109945] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2019] [Revised: 06/04/2019] [Accepted: 07/03/2019] [Indexed: 01/07/2023]
Abstract
The toxicity of C60(OH)30, C70(OH)30, and C120O(OH)n fullerenols, prepared by a new original method, has been studied. This method allowed us to obtain high-purity fullerenols and eliminate the risks of synthesis of preparations containing insoluble fractions contaminated with impurities such as fullerenes not completely reacted by hydroxylation. All fullerenols were detected inside cultured cells. The MTT assay as well as the analysis of apoptosis and cell cycle showed that С60(ОН)30 and С70(OH)30 are non-toxic for cultured V79 и HeLa cells at concentrations exceeding physiological levels by an order of magnitude. С120O(OH)n caused low toxicity. Studies in Drosophila melanogaster showed that any preparations used did not result in a decreased lifespan or in behavior abnormalities in flies.
Collapse
Affiliation(s)
- Olga Bolshakova
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Alina Borisenkova
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Marina Suyasova
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Victor Sedov
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Aleksandra Slobodina
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Svetlana Timoshenko
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Elena Varfolomeeva
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Ilia Golomidov
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Vasily Lebedev
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia
| | - Victor Aksenov
- Frank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Dubna 141980, Russia
| | - Svetlana Sarantseva
- Petersburg Nuclear Physics Institute, National Research Centre "Kurchatov Institute, Gatchina 188300, Russia.
| |
Collapse
|
3
|
Minois P, Bayardon J, Meunier-Prest R, Jugé S. [60]Fullerene l-Amino Acids and Peptides: Synthesis under Phase-Transfer Catalysis Using a Phosphine–Borane Linker. Electrochemical Behavior. J Org Chem 2017; 82:11358-11369. [DOI: 10.1021/acs.joc.7b01737] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Pauline Minois
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB-UMR 6302), BP 47870, Université de Bourgogne-Franche-Comté, 9 avenue A. Savary, Dijon 21078 Cedex, France
| | - Jérôme Bayardon
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB-UMR 6302), BP 47870, Université de Bourgogne-Franche-Comté, 9 avenue A. Savary, Dijon 21078 Cedex, France
| | - Rita Meunier-Prest
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB-UMR 6302), BP 47870, Université de Bourgogne-Franche-Comté, 9 avenue A. Savary, Dijon 21078 Cedex, France
| | - Sylvain Jugé
- Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB-UMR 6302), BP 47870, Université de Bourgogne-Franche-Comté, 9 avenue A. Savary, Dijon 21078 Cedex, France
| |
Collapse
|
4
|
Karimi M, Zangabad PS, Baghaee-Ravari S, Ghazadeh M, Mirshekari H, Hamblin MR. Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light. J Am Chem Soc 2017; 139:4584-4610. [PMID: 28192672 PMCID: PMC5475407 DOI: 10.1021/jacs.6b08313] [Citation(s) in RCA: 268] [Impact Index Per Article: 38.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Nanotechnology has begun to play a remarkable role in various fields of science and technology. In biomedical applications, nanoparticles have opened new horizons, especially for biosensing, targeted delivery of therapeutics, and so forth. Among drug delivery systems (DDSs), smart nanocarriers that respond to specific stimuli in their environment represent a growing field. Nanoplatforms that can be activated by an external application of light can be used for a wide variety of photoactivated therapies, especially light-triggered DDSs, relying on photoisomerization, photo-cross-linking/un-cross-linking, photoreduction, and so forth. In addition, light activation has potential in photodynamic therapy, photothermal therapy, radiotherapy, protected delivery of bioactive moieties, anticancer drug delivery systems, and theranostics (i.e., real-time monitoring and tracking combined with a therapeutic action to different diseases sites and organs). Combinations of these approaches can lead to enhanced and synergistic therapies, employing light as a trigger or for activation. Nonlinear light absorption mechanisms such as two-photon absorption and photon upconversion have been employed in the design of light-responsive DDSs. The integration of a light stimulus into dual/multiresponsive nanocarriers can provide spatiotemporal controlled delivery and release of therapeutic agents, targeted and controlled nanosystems, combined delivery of two or more agents, their on-demand release under specific conditions, and so forth. Overall, light-activated nanomedicines and DDSs are expected to provide more effective therapies against serious diseases such as cancers, inflammation, infections, and cardiovascular disease with reduced side effects and will open new doors toward the treatment of patients worldwide.
Collapse
Affiliation(s)
- Mahdi Karimi
- Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran
- Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, United States
| | - Parham Sahandi Zangabad
- Advanced Nanobiotechnology and Nanomedicine Research Group (ANNRG), Iran University of Medical Sciences, Tehran, Iran
- Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Science (TUOMS), Tabriz, Iran
- Department of Materials Science and Engineering, Sharif University of Technology, 11365-9466 Tehran, Iran
- Nanomedicine Research Association (NRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
| | - Soodeh Baghaee-Ravari
- Joint School of Nanoscience and Nanoengineering, University of North Carolina at Greensboro, Greensboro, North Carolina 27401, United States
| | - Mehdi Ghazadeh
- Joint School of Nanoscience and Nanoengineering, University of North Carolina at Greensboro, Greensboro, North Carolina 27401, United States
| | - Hamid Mirshekari
- Advanced Nanobiotechnology and Nanomedicine Research Group (ANNRG), Iran University of Medical Sciences, Tehran, Iran
| | - Michael R. Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, United States
- Department of Dermatology, Harvard Medical School, Boston, Massachusetts 02115, United States
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
5
|
Barbero CA, Yslas EI. Ecotoxicity Effects of Nanomaterials on Aquatic Organisms. APPLYING NANOTECHNOLOGY FOR ENVIRONMENTAL SUSTAINABILITY 2016. [DOI: 10.4018/978-1-5225-0585-3.ch014] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
The increasing production and use of engineered nanomaterials raise concerns about inadvertent exposure and the potential for adverse effects on the aquatic environment. The aim of this chapter is focused on studies of nanotoxicity in different models of aquatic organisms and their impact. Moreover, the chapter provides an overview of nanoparticles, their applications, and the potential nanoparticle-induced toxicity in aquatic organisms. The topics discussed in this chapter are the physicochemical characteristic of nanomaterials (size, aggregation, morphology, surface charge, reactivity, dissolution, etc.) and their influence on toxicity. Further, the text discusses the direct effect of nanomaterials on development stage (embryonic and adult) in aquatic organisms, the mechanism of action as well as the toxicity data of nanomaterials in different species.f action as well as the toxicity data of nanomaterials in different species.
Collapse
|
6
|
Competitive photometric enzyme immunoassay for fullerene C60 and its derivatives using a fullerene conjugated to horseradish peroxidase. Mikrochim Acta 2015. [DOI: 10.1007/s00604-015-1621-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
|